Neither medication substantially alters the pharmacokinetics of the other, making them safe to dose independently under medical supervision
Eli Lilly's stock is up more than 4% Tuesday after a successful late-stage trial for orforglipron, its oral GLP-1
10.1093/intimm/dxx031 Int Immunol
This new report does not negate those benefits but adds a layer of necessary nuance to their safety profile
Medically reviewed by Alan Lucks | MD , Alan Lucks MDPC Private Practice - New York on February 26th, 2026
Our Ursolic Acid and Retinal Overnight Reform contains Retinal, which is a one-step conversion from Retinoic Acid, meaning it works faster and is more potent than the popular retinol yet since it is formulated in a skin supportive base of Oat Oil, Hyaluronic Acid and Niacinamide it is absent of the usual side effects